glp-1 agonist drug interactions Receptor Agonists AJOG Expert Review: Glucagon-like peptide-1

Description

These are chemically modified salt forms that are distinct from the active ingredient in Ozempic or Wegovy, and their safety or effectiveness in humans has not been established

[DOI] [PMC free article] [PubMed] [Google Scholar] 258.Song H.J., Han H.R., Lee J.E., Kim J., Kim K.B., Nguyen T., Kim M.T

M., Liu, H., & Qu, S

Read more: To view or add a comment, sign in A new study presented at the European Society of Cardiology Congress 2025, powered by Truveta Data from more than 200,000 patients, found: Early discontinuation was linked to higher cardiovascular risks

All three medicationsZepbound, Wegovy, and Ozempicwork by influencing the bodys appetite and metabolism through the GLP-1 (glucagon-like peptide-1) pathway